We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0RIM market cap is 145.96M. The company's latest EPS is EUR -0.5962 and P/E is -0.67.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 4.35M | 4.91M | 7.72M | 7.71M | 4.87M |
Operating Income | -33.04M | -30.3M | -24.93M | -28.13M | -27.84M |
Net Income | -33.45M | -30.87M | -34.02M | -28.62M | -27.63M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 36.98M | 32.48M | 47.36M | 56.65M | 25.94M |
Total Liabilities | 13.11M | 21.97M | 35.69M | 40.66M | 41.22M |
Total Equity | 23.87M | 10.52M | 11.67M | 15.99M | -15.28M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -28.38M | -28.11M | -15.04M | -17.14M | -33.75M |
Investing | -663k | -102k | -376k | -16k | 172k |
Financing | -115k | 21.25M | 33.86M | 23.74M | 96k |
Market Cap | 145.96M |
Price to Earnings Ratio | -0.67 |
Price to Sales Ratio | 3.81 |
Price to Cash Ratio | 1.75 |
Price to Book Ratio | -1.21 |
Dividend Yield | - |
Shares Outstanding | 46.34M |
Average Volume (1 week) | 1.12k |
Average Volume (1 Month) | 3.32k |
52 Week Change | 0.00% |
52 Week High | 3.15 |
52 Week Low | 3.15 |
Spread (Intraday) | 0 (0%) |
Company Name | Gensight Biologics Sa |
Address |
74, rue du faubourg saint-antoine paris, paris 75012 |
Website | https://www.gensight-biologics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions